Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Joseph J Casella, DO
Family Practice · ANDOVER, NJ · NPI 1891781514
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 514 | 140 |
| Amlodipine Besylate | Amlodipine Besylate | 469 | 129 |
| Atorvastatin Calcium | Atorvastatin Calcium | 354 | 99 |
| Levothyroxine Sodium | Levothyroxine Sodium | 295 | 81 |
| Alprazolam | Alprazolam | 291 | 76 |
| Metformin Hcl | Metformin Hcl | 283 | 73 |
| Metoprolol Succinate | Metoprolol Succinate | 274 | 78 |
| Sertraline Hcl | Sertraline Hcl | 181 | 47 |
| Losartan Potassium | Losartan Potassium | 161 | 48 |
| Hydrochlorothiazide | Hydrochlorothiazide | 149 | 48 |
| Azithromycin | Azithromycin | 127 | 98 |
| Omeprazole | Omeprazole | 122 | 49 |
| Pantoprazole Sodium | Pantoprazole Sodium | 113 | 28 |
| Glimepiride | Glimepiride | 112 | 28 |
| Metformin Hcl Er | Metformin Hcl | 112 | 34 |
| Tamsulosin Hcl | Tamsulosin Hcl | 110 | 33 |
| Lisinopril | Lisinopril | 108 | 27 |
| Ezetimibe | Ezetimibe | 102 | 30 |
| Tramadol Hcl | Tramadol Hcl | 101 | 19 |
| Zolpidem Tartrate | Zolpidem Tartrate | 97 | 18 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 96 | 28 |
| Valsartan | Valsartan | 96 | 30 |
| Furosemide | Furosemide | 92 | 29 |
| Pravastatin Sodium | Pravastatin Sodium | 90 | 20 |
| Prednisone | Prednisone | 90 | 69 |
| Gabapentin | Gabapentin | 84 | 25 |
| Irbesartan | Irbesartan | 83 | 23 |
| Escitalopram Oxalate | Escitalopram Oxalate | 80 | 22 |
| Simvastatin | Simvastatin | 77 | 24 |
| Trazodone Hcl | Trazodone Hcl | 76 | 20 |
| Montelukast Sodium | Montelukast Sodium | 75 | 25 |
| Fluoxetine Hcl | Fluoxetine Hcl | 71 | 14 |
| Dexamethasone | Dexamethasone | 66 | 59 |
| Metoprolol Tartrate | Metoprolol Tartrate | 64 | 17 |
| Januvia | Sitagliptin Phosphate | 63 | 15 |
| Nebivolol Hcl | Nebivolol Hcl | 62 | 17 |
| Cefprozil | Cefprozil | 61 | 57 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 61 | suppressed |
| Jardiance | Empagliflozin | 60 | 15 |
| Methylprednisolone | Methylprednisolone | 59 | 48 |
| Allopurinol | Allopurinol | 57 | 17 |
| Warfarin Sodium | Warfarin Sodium | 57 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 51 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 48 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 47 | 13 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 47 | 12 |
| Duloxetine Hcl | Duloxetine Hcl | 46 | suppressed |
| Lorazepam | Lorazepam | 46 | 16 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 44 | 14 |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 44 | 12 |
| Carvedilol | Carvedilol | 44 | 15 |
| Clopidogrel | Clopidogrel Bisulfate | 42 | 11 |
| Mounjaro | Tirzepatide | 42 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 41 | 40 |
| Cefuroxime | Cefuroxime Axetil | 40 | 37 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 39 | suppressed |
| Ozempic | Semaglutide | 38 | suppressed |
| Potassium Chloride | Potassium Chloride | 38 | 14 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 37 | 20 |
| Mirtazapine | Mirtazapine | 37 | suppressed |
| Eliquis | Apixaban | 36 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 35 | suppressed |
| Olanzapine | Olanzapine | 34 | suppressed |
| Torsemide | Torsemide | 34 | 12 |
| Farxiga | Dapagliflozin Propanediol | 33 | 12 |
| Ramipril | Ramipril | 33 | 11 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 32 | 29 |
| Fluticasone Propionate | Fluticasone Propionate | 32 | 12 |
| Meloxicam | Meloxicam | 32 | 17 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 31 | 23 |
| Chlorthalidone | Chlorthalidone | 31 | suppressed |
| Nystatin | Nystatin | 31 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 30 | suppressed |
| Clonazepam | Clonazepam | 29 | suppressed |
| Cephalexin | Cephalexin | 28 | 24 |
| Myrbetriq | Mirabegron | 28 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 27 | suppressed |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 27 | 15 |
| Breo Ellipta | Fluticasone/Vilanterol | 27 | suppressed |
| Bupropion Xl | Bupropion Hcl | 26 | suppressed |
| Famotidine | Famotidine | 26 | 14 |
| Diazepam | Diazepam | 23 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 23 | suppressed |
| Risperidone | Risperidone | 23 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 22 | suppressed |
| Lactulose | Lactulose | 22 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 21 | 14 |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 21 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 20 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 20 | suppressed |
| Fenofibrate | Fenofibrate | 20 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 19 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 19 | suppressed |
| Frovatriptan Succinate | Frovatriptan Succinate | 19 | suppressed |
| Ondansetron Odt | Ondansetron | 19 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 18 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 17 | suppressed |
| Azelastine-Fluticasone | Azelastine/Fluticasone | 17 | suppressed |
| Betamethasone Valerate | Betamethasone Valerate | 17 | suppressed |
| Cefdinir | Cefdinir | 17 | 15 |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 17 | 12 |
| Finasteride | Finasteride | 17 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 17 | suppressed |
| Lamotrigine | Lamotrigine | 17 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 17 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 17 | suppressed |
| Timolol Maleate | Timolol Maleate | 17 | suppressed |
| Atenolol | Atenolol | 16 | suppressed |
| Cefadroxil | Cefadroxil | 16 | 14 |
| Celecoxib | Celecoxib | 16 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 16 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 16 | suppressed |
| Telmisartan | Telmisartan | 16 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 15 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 15 | suppressed |
| Digoxin | Digoxin | 14 | suppressed |
| Latanoprost | Latanoprost | 14 | suppressed |
| Linzess | Linaclotide | 14 | suppressed |
| Novolin N Flexpen | Insulin Nph Human Isophane | 14 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 13 | suppressed |
| Amoxicillin | Amoxicillin | 13 | suppressed |
| Budesonide | Budesonide | 13 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 13 | 13 |
| Prazosin Hcl | Prazosin Hcl | 13 | suppressed |
| Pregabalin | Pregabalin | 13 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 13 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 13 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 13 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 12 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 12 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 12 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 12 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 12 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 12 | suppressed |
| Memantine Hcl | Memantine Hcl | 12 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 12 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 12 | 11 |
| Amitriptyline Hcl | Amitriptyline Hcl | 11 | suppressed |
| Ascomp With Codeine | Codeine/Butalbital/Asa/Caffein | 11 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 11 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 11 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 11 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 11 | suppressed |
| Synthroid | Levothyroxine Sodium | 11 | suppressed |
| Tobramycin | Tobramycin | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error